Medtronic recently announced that it received clearance from the FDA and CE Mark approval for its LINQ II insertable cardiac monitor (ICM). The announcement notes that ICMs “are small, subcutaneously ...
Medtronic this week received regulatory approval for use of an implantable cardiac monitor in pediatric patients, giving doctors and parents greater peace of mind about the device's safety. On Tuesday ...
The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population The LINQ II system is a small (one-third the size of a AAA battery), wireless ICM ...
MOBILE, Ala. (WALA) -The FDA recently expanded use for the LINQ II™ insertable cardiac monitor (ICM) to patients ages 2 years and older who have heart rhythm issues. About one-third the size of a AAA ...
Next Generation ICM Offers Remote Programming with Improved Longevity and Enhanced Accuracy “In the current COVID-19 environment, the LINQ II system offers patients a seamless way to experience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results